Navamedic ASA (id:10464 NAVA)
25.40 NOK
Opening hours: 09:00 - 16:20 (Central European Standard Time: 12/24/2024 5:03:58 PM)
Exchange closed, opens in 15 hours 56 minutes
About Navamedic ASA
Market Capitalization 441.57M
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; prescription medicines covering obesity, Parkinson's disease, urology, and cardiology; and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was founded in 2002 and is headquartered in Oslo, Norway.
Headquarters (address) |
Henrik Ibsensgate 100 Oslo 0255 Norway |
Phone | 47 941 61 078 |
Website | https://navamedic.com |
Employees | 45 |
Sector | Healthcare |
Industry | Medical Distribution |
Ticker | NAVA |
Exchange | Oslo Stock Exchange |
Currency | NOK |
52 week range | 23.00 - 40.00 |
Market Capitalization | 441.57M |
Dividend yield forward | 15.72 % |
Dividend yield forward Norway (ID:238, base:105) | 17.03 % |
P/E trailing | 17.86 |
P/E forward | 14.79 |
Price/Sale | 3.00 |
Price/Book | 1.95 |
Beta | 3.00 |
EPS | 1.40 |
EPS Norway (ID:238, base:161) | 8.25 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Navamedic ASA has raised their dividend 15.72 years in a row. This is below the 42121.883700 year average in the 'Medical Distribution' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Navamedic ASA has raised their dividend 15.72 years in a row. This is below the 42121.883700 year average in the 'Medical Distribution' industry